Investor Relations

Stock Information

Date	Title
Toggle Summary10/01/19	Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay AUSTIN, Texas , Oct. 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration ( FDA ) 510(k) clearance for the ARIES ® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative,
Toggle Summary09/26/19	Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019 AUSTIN, Texas , Sept. 26, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, and Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global

Date	Event Details
Summary Toggle 10/02/19 1:50 PM EDT Wednesday, October 02, 2019 1:50 PM EDT	Luminex Corp at Cantor Global Healthcare Conference
Summary Toggle 09/10/19 2:05 PM EDT Tuesday, September 10, 2019 2:05 PM EDT	Luminex Corp at Morgan Stanley 17th Annual Global Healthcare Conference